Human Milk Oligosaccharides (HMOs)

Webinars, podcasts, courses, and articles about Human Milk Olisosaccharides (HMOs) and their contributions to brain, gut, and immune health.

The Role of 2'-FL HMO in Inflammation and the Possible Role in Food Allergy

In this course, identify research on how 2′-FL HMO helps narrow differences between formula and breast milk; review clinical studies supporting HMOs in immune support; and discuss why 2′-FL HMO may be relevant for the dietary management of infants with food allergy.

[CME] - Utilizing HMOs for Optimal Infant Nutrition Strategies

In this on-demand CME webinar, Lars Bode, PhD, and David J Hackam, MD, PhD, FACS, discuss the latest knowledge on the importance of HMOs on the gut-brain axis, neurocognitive development, and immune health; illustrate practical methods for incorporating recent findings that support the use of HMOs in infant nutrition strategies.

[CME] - The Role of HMOs on Various Parameters of Infant Health and Development

In this on-demand CME webinar, Lars Bode, PhD, and David J. Hackam, MD, PhD, FACS, explore the diversity of human milk oligosaccharides and their impact on gut dysbiosis and other parameters of infant health, including immune function and cognitive development. 

What is All the Fuss About the Gut Microbiome and 2'‐FL?

This article discusses the need for a healthy microbiome and how it is essential for appropriate development of the body’s immune responses. Human milk oligosaccharides, including 2′-fucosyllactose, promote the development of a healthy microbiome by promoting proliferation of beneficial bacteria and suppressing growth of pathogenic organisms.

How 2'-Fucosyllactose and 6'-Sialyllactose Relate to Infant Neurodevelopment, Maternal BMI and Diabetes Status

In this 11-minute podcast, Elena Oliveros, PhD, summarizes the results of a study she and her team published in Journal of Food Science, titled “Human Milk Levels of 2'-Fucosyllactose and 6'-Sialyllactose are Positively Associated with Infant Neurodevelopment and are Not Impacted by Maternal BMI or Diabetic Status.”

What Are Human Milk Oligosaccharides (HMOs)?

This infographic outlines how HMOs are unique prebiotics found naturally in human milk and offer particular benefits for a developing infant.

2'-FL Human Milk Oligosaccharides: Infographic

This infographic explains how 2'-fucosyllactose (2'-FL) human milk oligosaccharide (HMO) is the most abundant HMO, found in 75-85% of mothers' breast milk. HMO has system-wide effects in the gut, immune system and brain. It also explains the important outcomes and benefits of 2'-FL HMO  discovered through clinical and preclinical research.

Recent Advance in Infant Nutrition: Human Milk Oligosaccharides (HMOs)

This article describes how recent evidence reveals HMOs' abundance in breast milk and their various beneficial effects toward infants' health.

2'-Fucosyllactose: An Allergy-Modulating Human Milk Oligosaccharide?

This course reviews the emerging role of the human milk oligosaccharide, 2'-fucosyllactose (2'-FL), in allergy modulation and discusses 2'-FL potential mechanisms of action. It also recognizes the importance of breastfeeding. Originally presented on June 6, 2019 at the ESPGHAN Conference in Glasgow, Scotland.

A Review of the Immune Benefits of 2'-Fucosyllactose Human Milk Oligosaccharide and Pre-clinical Evidence of Its Effects on Food Allergy

The course reviews clinical studies supporting the immune benefits of 2'-fucosyllactose human milk oligosaccharide (2'-FL HMO); discusses preclinical evidence of 2'-FL HMO effects on food allergy and potential mechanisms of action; and describes the possible role of 2'-FL HMO in enhancing oral tolerance. Originally presented as a live webinar on June 3, 2020.

HMOs for Gut Health, Immunity, and Beyond

In this course, learn about the history, source, and biology of human milk oligosaccharides. This program was originally presented at the Nutrition & Growth Conference in Paris, France on March 1, 2018.

Human Milk Oligosaccharides: New in HMO Research

This course reviews human milk oligosaccharides (HMOs); summarizes potential direct and indirect HMO effects; discusses maternal genetic and environmental factors that influence HMO composition; and evaluates the current state of evidence for the role of HMOs in diseases. Originally presented at the HMO Summit on March 4, 2019 in Granada, Spain.

Related Human Milk Oligosaccharides (HMOs) Products